HighTower Advisors’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
OM
KCM
HighTower Advisors's GOSS Position: Q3 2026 in Review
HighTower Advisors sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 1,804 shares — an estimated $23.8K sold.
HighTower Advisors first reported a position in GOSS in Q3 2025 and held it in 4 quarters. The position peaked at $206K in Q4 2025. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- HighTower Advisors reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
- HighTower Advisors sold 1,804 Gossamer Bio shares in Q3 2026, an estimated $23.8K.
- HighTower Advisors first reported a position in Gossamer Bio in Q3 2025 and held it in 4 quarters.
- HighTower Advisors's Gossamer Bio position peaked at $206K in Q4 2025.
- 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.